Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan

Gulnoza Zokirova; Asalya Abduvakhitova; Durdona Saipova; Djurat Zakirov; Muyassar Zufarova

doi:10.63946/cajn/19517

Congress Abstract

Oct 06, 2026 4 1

Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan

Gulnoza Zokirova ¹ ^* ,

Asalya Abduvakhitova ¹,

Durdona Saipova ¹,

Djurat Zakirov ¹,

Muyassar Zufarova ¹

¹ National Specialized Research and Practical Medical Center for Nephrology and Kidney Transplantation, Tashkent, Uzbekistan ^* Corresponding Author

Central Asian Journal of Nephrology, 2(2, Suppl. 1), 2026, cajn_A28, https://doi.org/10.63946/cajn/19517

Publication date: Oct 06, 2026

Full Text (PDF)

ABSTRACT

Systemic Lupus Erythematosus; Lupus Nephritis; Belimumab; Acute Kidney Injury; Renal Replacement Therapy

KEYWORDS

systemic lupus erythematosus lupus nephritis belimumab acute kidney injury renal replacement therapy.

CITATION (Vancouver)

Zokirova G, Abduvakhitova A, Saipova D, Zakirov D, Zufarova M. Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan. Central Asian Journal of Nephrology. 2026;2(2, Suppl. 1):cajn_A28. https://doi.org/10.63946/cajn/19517

Show other citation styles Hide other citation styles

APA

Zokirova, G., Abduvakhitova, A., Saipova, D., Zakirov, D., & Zufarova, M. (2026). Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan. Central Asian Journal of Nephrology, 2(2, Suppl. 1), cajn_A28. https://doi.org/10.63946/cajn/19517

Harvard

Zokirova, G., Abduvakhitova, A., Saipova, D., Zakirov, D., and Zufarova, M. (2026). Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan. Central Asian Journal of Nephrology, 2(2, Suppl. 1), cajn_A28. https://doi.org/10.63946/cajn/19517

AMA

Zokirova G, Abduvakhitova A, Saipova D, Zakirov D, Zufarova M. Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan. Central Asian Journal of Nephrology. 2026;2(2, Suppl. 1), cajn_A28. https://doi.org/10.63946/cajn/19517

Chicago

Zokirova, Gulnoza, Asalya Abduvakhitova, Durdona Saipova, Djurat Zakirov, and Muyassar Zufarova. "Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan". Central Asian Journal of Nephrology 2026 2 no. 2, Suppl. 1 (2026): cajn_A28. https://doi.org/10.63946/cajn/19517

MLA

Zokirova, Gulnoza et al. "Application of Belimumab in the Pathogenetic Therapy of Systemic Lupus Erythematosus with Class IV Lupus Nephritis and Acute Kidney Injury in Uzbekistan". Central Asian Journal of Nephrology, vol. 2, no. 2, Suppl. 1, 2026, cajn_A28. https://doi.org/10.63946/cajn/19517

REFERENCES

---

LICENSE

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.